{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:47Z","timestamp":1786118927800,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/gme.0b013e318182f84b","type":"journal-article","created":{"date-parts":[[2008,9,9]],"date-time":"2008-09-09T03:20:54Z","timestamp":1220930454000},"page":"885-889","source":"Crossref","is-referenced-by-count":81,"title":["Measuring symptom relief in studies of vaginal and vulvar atrophy"],"prefix":"10.1097","volume":"15","author":[{"given":"Bruce","family":"Ettinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Hait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen Z.","family":"Reape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-14-20210227","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women.","volume":"4","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-14-20210227","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/01.AOG.0000158120.47542.18","article-title":"Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.","volume":"105","author":"Barnabei","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R5-14-20210227","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00042192-200007050-00005","article-title":"Suppression of vasomotor and vulvovaginal symptoms with continuous oral 17-estradiol.","volume":"7","author":"Notelovitz","year":"2000","journal-title":"Menopause"},{"key":"R6-14-20210227","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00042192-200007030-00005","article-title":"17-Estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.","volume":"7","author":"Rioux","year":"2000","journal-title":"Menopause"},{"key":"R7-14-20210227","first-page":"346","article-title":"Study Groups on the Effects of Raloxifene HCI with Low-Dose Premarin Vaginal Cream. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.","volume":"101","author":"Parsons","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R8-14-20210227","first-page":"45","article-title":"Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women.","volume":"10","author":"Pinkerton","year":"2003","journal-title":"Menopause"},{"key":"R9-14-20210227","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.gme.0000182802.06762.b2","article-title":"Efficacy of a new, oral estradiol acetate formulation for relief of menopausal symptoms.","volume":"13","author":"Speroff","year":"2006","journal-title":"Menopause"},{"key":"R10-14-20210227","first-page":"823","article-title":"Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms.","volume":"102","author":"Speroff","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R11-14-20210227","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/01.AOG.0000254160.62588.41","article-title":"Low doses of transdermal estradiol gel for treatment of symptomatic postmenopausal women.","volume":"109","author":"Simon","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R13-14-20210227","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer.","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"key":"R14-14-20210227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5122(03)00240-8","article-title":"Low-dose (0.3 mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis.","volume":"47","author":"Marx","year":"2004","journal-title":"Maturitas"},{"key":"R15-14-20210227","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.","volume":"75","author":"Utian","year":"2001","journal-title":"Fert Steril"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/gme.0b013e318182f84b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:07:59Z","timestamp":1786036079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-200815050-00014"}},"subtitle":["the most bothersome symptom approach"],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e318182f84b","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}